Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Makor Capital Hires Lionel Botbol As Global Head Of Makor Investment Banking Division
-
Westwater Resources Announces Year-end 2020 Results and Business Update
-
Tilray (TLRY) PT Raised to $30.25 at Cantor Fitzgerald; 'Prefer to Play Merger Via APHA'
-
4D Pharma to Participate in Upcoming Cantor Fitzgerald Microbiome Leaders Panel
-
Companies with NDRs 2/16
-
Galmed Pharmaceuticals (GLMD) Announces Proposed Offering of Ordinary Shares
-
Galmed Pharmaceuticals Announces Proposed Offering of Ordinary Shares
-
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
-
CF Acquisition Corp. IV Announces Separate Trading of Class A Common Stock and Warrants
-
CF Acquisition Corp. IV Announces Separate Trading of Class A Common Stock and Warrants
-
NexImmune (NEXI) IPO Opens 35% Higher
-
VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock
-
Sanara MedTech (SMTI) Prices 1.1M Share Common Stock Offering at $25/Each
-
Sanara MedTech Inc. Announces Pricing of Public Offering
-
Corvus Pharma (CRVS) Announces Pricing of Public Offering of Common Stock
-
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
HilltopSecurities Welcomes Brian Branigan to Fixed Income Capital Markets
-
MoneyLion to Become Publicly Traded via Merger with Fusion Acquisition Corp. (FUSE)
-
MoneyLion, America’s Leading Digital Financial Platform, to Become Publicly Traded via Merger with Fusion Acquisition Corp. (NYSE: FUSE)
-
Aurora Cannabis (ACB:CN) (ACB) PT Raised to Cdn$18 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Amicus Therapeutics (FOLD) to Neutral
-
NexImmune Inc. (NEXI) Prices 6.471M Share IPO at $17/Sh
-
NexImmune Announces Pricing of Upsized Initial Public Offering
-
NexImmune Announces Pricing of Upsized Initial Public Offering
-
Pivotal Investment Corp. III Announces Closing of $276,000,000 Initial Public Offering
-
Crown PropTech Acquisitions Announces Closing of $276 Million Initial Public Offering Including Full Exercise by Underwriters to Purchase Additional Shares
-
Sanara MedTech (SMTI) to Offer Common Stock
-
Corvus Pharma (CRVS) to Offer Common Stock
-
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Sanara MedTech Inc. Announces Proposed Public Offering of Common Stock
-
Ur-Energy (URE:CN) (URG) PT Raised to $1.50 at Cantor Fitzgerald
-
Critical Elements Closes $15 Million Bought Deal Private Placement of Units
-
Ocuphire to Participate in the 2021 BIO CEO & Investor Conference and Cantor Fitzgerald’s Panel on Eyeing Key Events in the Ophthalmology Space in 2021
-
TherapeuticsMD (TXMD) Prices $110M Share Common Offering
-
TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock
-
Kadmon Announces Pricing of $200 Million Convertible Senior Notes Offering with 100% Capped Call Transactions
-
Humanigen to Present and Participate at Multiple Upcoming Investor and Industry Conferences
-
Jushi Holding (JUSHF) PT Raised to $8.50 at Cantor Fitzgerald
-
Ayr Strategies (AYRWF) PT Raised to $39 at Cantor Fitzgerald
-
Green Thumb Industries (GTBIF) PT Raised to $62 at Cantor Fitzgerald
-
KalVista Pharmaceuticals (KALV) Prices 5.375M Share Upsized Common Offering at $36/Sh
-
Nanox (NNOX) Prices 3.09M Share Secondary Offering at $62.50/Sh
-
KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock
-
Nanox Announces Pricing of Secondary Offering of Ordinary Shares
-
Orchid Island Capital Announces February 2021 Monthly Dividend and January 31, 2021 RMBS Portfolio Characteristics
-
TherapeuticsMD (TXMD) Announces Underwritten Public Offering of its Common Stock
-
TherapeuticsMD Announces Underwritten Public Offering of its Common Stock
-
Veru, Inc. (VERU) PT Raised to $24 at Cantor Fitzgerald
-
Volitionrx Limited (VNRX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
-
VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock

